Portal de Periódicos da CAPES

Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV

2015; Elsevier BV; Volume: 126; Issue: 1 Linguagem: Inglês

10.1182/blood-2015-01-617993

1528-0020

Susanne Saußele, Marie-Paloma Krauß, Rüdiger Hehlmann, Michael Lauseker, Ulrike Proetel, Lida Kalmanti, Benjamin Hanfstein, Alice Fabarius, Doris Kraemer, Wolfgang E. Berdel, Martin Bentz, Peter Staib, Maike de Wit, Martin Wernli, Florian Zettl, Holger Hebart, Markus Hahn, Jochen Heymanns, Ingo Schmidt‐Wolf, Norbert Schmitz, Michael J. Eckart, W. Gaßmann, A. Bartholomäus, Antonio Pezzutto, Elisabeth Oppliger Leibundgut, Dominik Heim, Stefan W. Krause, Andreas Burchert, Wolf‐Karsten Hofmann, Joerg Hasford, Andreas Hochhaus, Markus Pfirrmann, Martin C. Müller,

Lymphoma Diagnosis and Treatment

Key Points There is a strong negative association between comorbidities at diagnosis and overall survival. There is no negative effect of comorbidities on remission rates and progression to advanced phases in CML.